Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- SkyePharma plc

4 Jan 2006 11:43

HBOS PLC04 January 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBOS plc and its subsidiariesCompany dealt in SkyePharma plcClass of relevant security to which the Ord 10pdealings being disclosed relate (Note 2)Date of dealing 3 January 2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 68,252,661 (9.055%)(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 68,252,661 (9.055%) Nil (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal Nil Nil (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 12,457 £0.498 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneypaid/name,e.g. call selling, securities to price American, date received per unitoption purchasing, which the European etc. (Note 5) varying etc. option relates (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. N/A .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 4 January 2006Contact name Kenny MelvilleTelephone number 0131 243 8671If a connected EFM, name of offeree/offeror with whichconnectedIf a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20163:20 pmRNSForm 8.3 - Skypepharma PLC
1st Jun 201612:29 pmRNSForm 8.3 - Skyepharma PLC
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
1st Jun 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
1st Jun 201610:51 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
1st Jun 201610:09 amRNSForm 8.3 - Vectura Group plc
1st Jun 20169:30 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
31st May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
31st May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
31st May 20161:24 pmRNSForm 8.3 - Vectura Group Plc
31st May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
31st May 201610:36 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
31st May 20169:37 amRNSForm 8.3 - Vectura Group plc
31st May 20168:55 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
31st May 20167:00 amRNSForm 8.3 - Skyepharma PLC
27th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
27th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
27th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
27th May 20161:58 pmRNSForm 8.3 - [Skyepharma plc]
27th May 20161:55 pmRNSForm 8.3 - Vectura Group Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
27th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
27th May 201610:24 amRNSForm 8.3 - Vectura Group plc
27th May 201610:16 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
27th May 20169:49 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
26th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
26th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
26th May 20162:46 pmRNSForm 8.3 - Skyepharma
26th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
26th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
26th May 20169:04 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
26th May 20168:52 amRNSForm 8.3 - Vectura Group plc
25th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
25th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
25th May 20163:23 pmRNSForm 8.3 - Skyepharma Plc
25th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
25th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
25th May 201610:13 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
25th May 20169:28 amRNSForm 8.3 - Vectura Group plc
25th May 20169:07 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20163:30 pmRNSForm 8.3 - [VEC/SKP]
24th May 20163:30 pmRNSForm 8.3 - [SKP/VEC]
24th May 20163:20 pmRNSForm 8.3 - Skyepharma PLC
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
24th May 201610:55 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
24th May 20169:37 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
24th May 20169:33 amRNSForm 8.3 - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.